Artificial sweetener is a growing threat for metabolic syndrome: why is extra attention required?

doi:10.2144/fsoa-2023-0092

. 2023 Jun 23;9(8):FSO880.

doi: 10.2144/fsoa-2023-0092. eCollection 2023 Sep.

Artificial sweetener is a growing threat for metabolic syndrome: why is extra attention required?

Sarvesh Sabarathinam^{1

2

3}, Dhivya Dhanasekaran³, Nila Ganamurali³

Affiliations

¹ Drug testing Laboratory, Interdisciplinary Institute of Indian System of Medicine (IIISM), SRM Institute of Science & Technology, Kattankulathur, Chennai, Tamil Nadu, 603203, India.
² Clinical Trial Unit, Metabolic Ward, Interdisciplinary Institute of Indian System of Medicine (IIISM), SRM Institute of Science & Technology, Kattankulathur, Chennai, Tamil Nadu, 603203, India.
³ Certificate Program-Analytical Techniques in Herbal Drug Industry, Interdisciplinary Institute of Indian System of Medicine (IIISM), SRM Institute of Science & Technology, Kattankulathur, Chennai, Tamil Nadu, 603203, India.

PMID: 37621846
PMCID: PMC10445552
DOI: 10.2144/fsoa-2023-0092

Artificial sweetener is a growing threat for metabolic syndrome: why is extra attention required?

Sarvesh Sabarathinam et al. Future Sci OA. 2023.

. 2023 Jun 23;9(8):FSO880.

doi: 10.2144/fsoa-2023-0092. eCollection 2023 Sep.

Authors

Sarvesh Sabarathinam^{1

2

3}, Dhivya Dhanasekaran³, Nila Ganamurali³

Affiliations

¹ Drug testing Laboratory, Interdisciplinary Institute of Indian System of Medicine (IIISM), SRM Institute of Science & Technology, Kattankulathur, Chennai, Tamil Nadu, 603203, India.
² Clinical Trial Unit, Metabolic Ward, Interdisciplinary Institute of Indian System of Medicine (IIISM), SRM Institute of Science & Technology, Kattankulathur, Chennai, Tamil Nadu, 603203, India.
³ Certificate Program-Analytical Techniques in Herbal Drug Industry, Interdisciplinary Institute of Indian System of Medicine (IIISM), SRM Institute of Science & Technology, Kattankulathur, Chennai, Tamil Nadu, 603203, India.

PMID: 37621846
PMCID: PMC10445552
DOI: 10.2144/fsoa-2023-0092

No abstract available

Keywords: bioanalysis; biochemistry; bioinformatics; cardiovascular; clinical pharmacology; endocrinology; epidemiology; metabolism; pharmacology; toxicology.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest disclosure The authors declare that there are no conflicts of interest present.

References

1. Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther. Adv. Cardiovasc. Dis. 11(8), 215–225 (2017). - PMC - PubMed
1. Zatterale F, Longo M, Naderi J et al. Chronic adipose tissue inflammation linking obesity to insulin resistance and Type 2 diabetes. 10 (2020). - PMC - PubMed
1. Swarup S, Goyal A, Grigorova Y, Zeltser R. Metabolic syndrome. In: StatPearls. StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC, FL, USA: (2023). - PubMed
1. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome. 112(17), 2735–2752 (2005). - PubMed
1. Liang X, Or B, Tsoi MF, Cheung CL, Cheung BMY. Prevalence of metabolic syndrome in the United States National Health and Nutrition Examination Survey 2011–18. Postgrad. Med. J. (2023). - PubMed

LinkOut - more resources

Full Text Sources

[1] Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther. Adv. Cardiovasc. Dis. 11(8), 215–225 (2017). - PMC - PubMed

[2] Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther. Adv. Cardiovasc. Dis. 11(8), 215–225 (2017). - PMC - PubMed

[3] Zatterale F, Longo M, Naderi J et al. Chronic adipose tissue inflammation linking obesity to insulin resistance and Type 2 diabetes. 10 (2020). - PMC - PubMed

[4] Zatterale F, Longo M, Naderi J et al. Chronic adipose tissue inflammation linking obesity to insulin resistance and Type 2 diabetes. 10 (2020). - PMC - PubMed

[5] Swarup S, Goyal A, Grigorova Y, Zeltser R. Metabolic syndrome. In: StatPearls. StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC, FL, USA: (2023). - PubMed

[6] Swarup S, Goyal A, Grigorova Y, Zeltser R. Metabolic syndrome. In: StatPearls. StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC, FL, USA: (2023). - PubMed

[7] Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome. 112(17), 2735–2752 (2005). - PubMed

[8] Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome. 112(17), 2735–2752 (2005). - PubMed

[9] Liang X, Or B, Tsoi MF, Cheung CL, Cheung BMY. Prevalence of metabolic syndrome in the United States National Health and Nutrition Examination Survey 2011–18. Postgrad. Med. J. (2023). - PubMed

[10] Liang X, Or B, Tsoi MF, Cheung CL, Cheung BMY. Prevalence of metabolic syndrome in the United States National Health and Nutrition Examination Survey 2011–18. Postgrad. Med. J. (2023). - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Artificial sweetener is a growing threat for metabolic syndrome: why is extra attention required?

Affiliations

Artificial sweetener is a growing threat for metabolic syndrome: why is extra attention required?

Authors

Affiliations

Conflict of interest statement

Similar articles

References

LinkOut - more resources

Full Text Sources